564 related articles for article (PubMed ID: 17707267)
1. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity modulated brachytherapy or EBRT for prostate cancer patients.
Prada PJ; Fernández J; Martinez AA; de la Rúa A; Gonzalez JM; Fernandez JM; Juan G
Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):95-102. PubMed ID: 17707267
[TBL] [Abstract][Full Text] [Related]
2. Transperineal injection of hyaluronic acid in anterior perirectal fat to decrease rectal toxicity from radiation delivered with intensity-modulated brachytherapy or EBRT for prostate cancer patients: in regard to Prada et al. (Int J Radiat Oncol Biol Phys 2007;69:95-102.).
Vordermark D; Guckenberger M; Baier K; Markert K
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):316-7. PubMed ID: 18406899
[No Abstract] [Full Text] [Related]
3. Transperineal injection of hyaluronic acid in the anterior perirectal fat to decrease rectal toxicity from radiation delivered with low-dose-rate brachytherapy for prostate cancer patients.
Prada PJ; Gonzalez H; Menéndez C; Llaneza A; Fernández J; Santamarta E; Ricarte PP
Brachytherapy; 2009; 8(2):210-217. PubMed ID: 19213607
[TBL] [Abstract][Full Text] [Related]
4. Cross-linked hyaluronan gel reduces the acute rectal toxicity of radiotherapy for prostate cancer.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin J; Lizarde J; Macedo J; Ravera J; Tokita KM
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):824-30. PubMed ID: 20510195
[TBL] [Abstract][Full Text] [Related]
5. A dosimetric study of polyethylene glycol hydrogel in 200 prostate cancer patients treated with high-dose rate brachytherapy±intensity modulated radiation therapy.
Strom TJ; Wilder RB; Fernandez DC; Mellon EA; Saini AS; Hunt DC; Pow-Sang JM; Spiess PE; Sexton WJ; Poch MA; Biagioli MC
Radiother Oncol; 2014 Apr; 111(1):126-31. PubMed ID: 24746567
[TBL] [Abstract][Full Text] [Related]
6. Prostate hypofractionated radiation therapy: injection of hyaluronic acid to better preserve the rectal wall.
Chapet O; Udrescu C; Devonec M; Tanguy R; Sotton MP; Enachescu C; Colombel M; Azria D; Jalade P; Ruffion A
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):72-6. PubMed ID: 23290444
[TBL] [Abstract][Full Text] [Related]
7. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric implications of an injection of hyaluronic acid for preserving the rectal wall in prostate stereotactic body radiation therapy.
Chapet O; Udrescu C; Tanguy R; Ruffion A; Fenoglietto P; Sotton MP; Devonec M; Colombel M; Jalade P; Azria D
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):425-32. PubMed ID: 24411613
[TBL] [Abstract][Full Text] [Related]
9. High-dose-rate interstitial brachytherapy as monotherapy in one fraction and transperineal hyaluronic acid injection into the perirectal fat for the treatment of favorable stage prostate cancer: treatment description and preliminary results.
Prada PJ; Jimenez I; González-Suárez H; Fernández J; Cuervo-Arango C; Mendez L
Brachytherapy; 2012; 11(2):105-10. PubMed ID: 21917528
[TBL] [Abstract][Full Text] [Related]
10. Human collagen injections to reduce rectal dose during radiotherapy.
Noyes WR; Hosford CC; Schultz SE
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1918-22. PubMed ID: 21514738
[TBL] [Abstract][Full Text] [Related]
11. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
12. Dose-volume impact in high-dose-rate Iridium-192 brachytherapy as a boost to external beam radiotherapy for localized prostate cancer--a phase II study.
Pinkawa M; Fischedick K; Treusacher P; Asadpour B; Gagel B; Piroth MD; Borchers H; Jakse G; Eble MJ
Radiother Oncol; 2006 Jan; 78(1):41-6. PubMed ID: 16271785
[TBL] [Abstract][Full Text] [Related]
13. Technique of Injection of Hyaluronic Acid as a Prostatic Spacer and Fiducials Before Hypofractionated External Beam Radiotherapy for Prostate Cancer.
Boissier R; Udrescu C; Rebillard X; Terrier JE; Faix A; Chapet O; Azria D; Devonec M; Paparel P; Ruffion A
Urology; 2017 Jan; 99():265-269. PubMed ID: 27725233
[TBL] [Abstract][Full Text] [Related]
14. Application technique: placement of a prostate-rectum spacer in men undergoing prostate radiation therapy.
Hatiboglu G; Pinkawa M; Vallée JP; Hadaschik B; Hohenfellner M
BJU Int; 2012 Dec; 110(11 Pt B):E647-52. PubMed ID: 22788857
[TBL] [Abstract][Full Text] [Related]
15. Hydrogel Spacer Prospective Multicenter Randomized Controlled Pivotal Trial: Dosimetric and Clinical Effects of Perirectal Spacer Application in Men Undergoing Prostate Image Guided Intensity Modulated Radiation Therapy.
Mariados N; Sylvester J; Shah D; Karsh L; Hudes R; Beyer D; Kurtzman S; Bogart J; Hsi RA; Kos M; Ellis R; Logsdon M; Zimberg S; Forsythe K; Zhang H; Soffen E; Francke P; Mantz C; Rossi P; DeWeese T; Hamstra DA; Bosch W; Gay H; Michalski J
Int J Radiat Oncol Biol Phys; 2015 Aug; 92(5):971-977. PubMed ID: 26054865
[TBL] [Abstract][Full Text] [Related]
16. High-dose-rate brachytherapy for prostate cancer in a previously radiated patient with polyethylene glycol hydrogel spacing to reduce rectal dose: case report and review of the literature.
Nguyen PL; Devlin PM; Beard CJ; Orio PF; O'Leary MP; Wolfsberger LD; O'Farrell DA; Sweeney CM; Hadaschik BA; Hohenfellner M; Hatiboglu G
Brachytherapy; 2013; 12(1):77-83. PubMed ID: 22543116
[TBL] [Abstract][Full Text] [Related]
17. Cross-linked hyaluronan gel improves the quality of life of prostate cancer patients undergoing radiotherapy.
Wilder RB; Barme GA; Gilbert RF; Holevas RE; Kobashi LI; Reed RR; Solomon RS; Walter NL; Chittenden L; Mesa AV; Agustin JK; Lizarde J; Macedo JC; Ravera J; Tokita KM
Brachytherapy; 2011; 10(1):44-50. PubMed ID: 20591748
[TBL] [Abstract][Full Text] [Related]
18. Placement of an absorbable rectal hydrogel spacer in patients undergoing low-dose-rate brachytherapy with palladium-103.
Taggar AS; Charas T; Cohen GN; Boonyawan K; Kollmeier M; McBride S; Mathur N; Damato AL; Zelefsky MJ
Brachytherapy; 2018; 17(2):251-258. PubMed ID: 29241706
[TBL] [Abstract][Full Text] [Related]
19. Intensity modulated proton and photon therapy for early prostate cancer with or without transperineal injection of a polyethylen glycol spacer: a treatment planning comparison study.
Weber DC; Zilli T; Vallee JP; Rouzaud M; Miralbell R; Cozzi L
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):e311-8. PubMed ID: 22999271
[TBL] [Abstract][Full Text] [Related]
20. Genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with Hypofractionated External beam radiotherapy for localized prostate cancer: an analysis to determine the correlation between dose-volume histogram parameters in HDR brachytherapy and severity of toxicity.
Ishiyama H; Kitano M; Satoh T; Kotani S; Uemae M; Matsumoto K; Okusa H; Tabata K; Baba S; Hayakawa K
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):23-8. PubMed ID: 19243900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]